Normal allele: CC
Polymorphisms in the FK506 protein gene are associated with attention deficit hyperactivity disorder and increased daily cortisol levels. It is also associated with an increased risk of depression with an odds ratio of 1.39.
Polymorphism rs1360780 is related to topics like this:
Research and publications:
15637659 Linkage disequilibrium patterns and tagSNP transferability among European populations.
18180755 Family-based association of FKBP5 in bipolar disorder.
18597649 Genetic variants in FKBP5 affecting response to antidepressant drug treatment.
19455174 Psychobiology and molecular genetics of resilience.
19540311 Genetics of anxiety and trauma-related disorders.
19676097 FKBP5 polymorphisms and antidepressant response in geriatric depression.
20393453 Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder.
20504254 Pharmacogenomics of suicidal events.
20547006 FKBP5 and resistant attachment predict cortisol reactivity in infants: gene-environment interaction.
20551900 FKBP5 polymorphisms modify the effects of childhood trauma.
20856915 Tailoring therapeutic strategies for treating posttraumatic stress disorder symptom clusters.
21112363 Association of FKBP5 gene haplotypes with completed suicide in the Japanese population.
21172166 Pharmacogenetics of antidepressant response.
21225419 Gene-environment interactions: early life stress and risk for depressive and anxiety disorders.
21333900 The role of genetics in IBS
22030708 Genome-wide association study of antidepressant treatment-emergent suicidal ideation.
22134958 Relationship between FKBP5 polymorphisms and depression symptoms among kidney transplant recipients.
22213790 Interaction between FKBP5 and childhood trauma and risk of aggressive behavior.
22979952 FKBP5 and emotional neglect interact to predict individual differences in amygdala reactivity.
23733030 Pharmacogenetics in major depression: a comprehensive meta-analysis.
24099078 FKBP5 and CRHR1 polymorphisms moderate the stress-physical health association in a national sample.
24128936 PharmGKB summary: venlafaxine pathway.
24166410 HPA axis genetic variation, cortisol and psychosis in major depression.
24253961 FKBP5 genotype and structural integrity of the posterior cingulum.
24319431 Mechanisms of antidepressant resistance.
24596569 Gene-environment interactions and intermediate phenotypes: early trauma and depression.
24632812 Transcriptomic analysis of the effects of a fish oil enriched diet on murine brains.
24756342 Role of FKBP5 in emotion processing: results on amygdala activity, connectivity and volume.
24766650 Drug addiction and stress-response genetic variability: association study in African Americans.
24845178 Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype.
24856550 FKBP5 polymorphism is associated with major depression but not with bipolar disorder.
24944790 Screening for 392 polymorphisms in 141 pharmacogenes.
25462914 FKBP5 moderation of depressive symptoms in peer victimized, post-institutionalized children.
26189450 Genetic Moderation of Stress Effects on Corticolimbic Circuitry.
26424511 Psychiatric symptoms in adolescents: FKBP5 genotype--early life adversity interaction effects.
26630184 Association between FKBP5 Functional Polymorphisms and Completed Suicide.
26801675 FKBP5 modulates the hippocampal connectivity deficits in depression: a study in twins.
26885402 Linking Mitochondria to Synapses: New Insights for Stress-Related Neuropsychiatric Disorders.
27038411 STRUCTURAL AND FUNCTIONAL CONNECTIVITY IN POSTTRAUMATIC STRESS DISORDER: ASSOCIATIONS WITH FKBP5.
27062383 The Effect of Nicotine on HPA Axis Activity in Females is Modulated by the FKBP5 Genotype.
27196697 FKBP5 genotype interacts with early life trauma to predict heavy drinking in college students.
27448712 Associations between the FKBP5 haplotype, exposure to violence and anxiety in females.
27664120 Reduced DNA methylation of FKBP5 in Cushing's syndrome.